江蘇省(sheng)(sheng)中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)研究(jiu)院(yuan)(yuan)、江蘇省(sheng)(sheng)中(zhong)(zhong)(zhong)西醫(yi)(yi)結合醫(yi)(yi)院(yuan)(yuan)始建(jian)于1956年(nian),首任所長為著名(ming)中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)學(xue)(xue)家(jia)(jia)、學(xue)(xue)部委員(院(yuan)(yuan)士(shi))葉(xie)桔(jie)泉教(jiao)授(shou),2013年(nian)6月,成(cheng)為中(zhong)(zhong)(zhong)國(guo)(guo)中(zhong)(zhong)(zhong)醫(yi)(yi)科學(xue)(xue)院(yuan)(yuan)首個地方分院(yuan)(yuan),是(shi)江蘇省(sheng)(sheng)專(zhuan)業從事中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)研究(jiu)的省(sheng)(sheng)屬(shu)公(gong)益類(lei)科研機構、綜合性三(san)級甲等中(zhong)(zhong)(zhong)西醫(yi)(yi)結合醫(yi)(yi)院(yuan)(yuan),同時還是(shi)南京中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)大學(xue)(xue)附屬(shu)中(zhong)(zhong)(zhong)西醫(yi)(yi)結合醫(yi)(yi)院(yuan)(yuan)、第三(san)臨床(chuang)醫(yi)(yi)學(xue)(xue)院(yuan)(yuan)、全國(guo)(guo)重點中(zhong)(zhong)(zhong)西醫(yi)(yi)結合醫(yi)(yi)院(yuan)(yuan)、國(guo)(guo)家(jia)(jia)藥(yao)物臨床(chuang)試驗機構、國(guo)(guo)家(jia)(jia)中(zhong)(zhong)(zhong)醫(yi)(yi)住院(yuan)(yuan)醫(yi)(yi)師規范化培訓(xun)基(ji)地、國(guo)(guo)家(jia)(jia)中(zhong)(zhong)(zhong)醫(yi)(yi)應急救治醫(yi)(yi)療隊、江蘇省(sheng)(sheng)中(zhong)(zhong)(zhong)醫(yi)(yi)綜合類(lei)緊(jin)急醫(yi)(yi)學(xue)(xue)救援(yuan)基(ji)地、美國(guo)(guo)心(xin)臟協會(AHA)授(shou)權的專(zhuan)業急救技(ji)能培訓(xun)基(ji)地。醫(yi)(yi)院(yuan)(yuan)2017年(nian)被納(na)入(ru)全國(guo)(guo)中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)傳(chuan)承(cheng)創新(xin)工程省(sheng)(sheng)級中(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)科研機構項目儲(chu)備庫(ku),2018年(nian)成(cheng)為第二批國(guo)(guo)家(jia)(jia)中(zhong)(zhong)(zhong)醫(yi)(yi)臨床(chuang)研究(jiu)基(ji)地建(jian)設單位(wei)。
醫(yi)(yi)院(yuan)近(jin)5年(nian)來在科(ke)(ke)研(yan)領域(yu)取(qu)得了(le)令人矚(zhu)目(mu)的成就,中(zhong)標科(ke)(ke)研(yan)項目(mu)350項,其中(zhong)國(guo)家級(ji)91項、包括國(guo)家新藥創制重點專項3項;省部級(ji)46項。醫(yi)(yi)院(yuan)連(lian)續3年(nian)國(guo)家自然科(ke)(ke)學(xue)基(ji)金(jin)項目(mu)的中(zhong)標數和中(zhong)標率居國(guo)內同類型中(zhong)醫(yi)(yi)藥科(ke)(ke)研(yan)機構前列,2016年(nian)首獲國(guo)家自然基(ji)金(jin)委優秀青(qing)年(nian)基(ji)金(jin)。醫(yi)(yi)院(yuan)并(bing)先后(hou)榮獲各級(ji)各類科(ke)(ke)研(yan)成果(guo)獎(jiang)21項,獲國(guo)內外(wai)專利57項,取(qu)得臨床批件(jian)、制劑(ji)注冊批件(jian)2個(ge);發表論文(wen)近(jin)1737篇,其中(zhong)在SCI期刊發表434篇,最(zui)高影響因(yin)子(zi)36.5。醫(yi)(yi)院(yuan)與(yu)上(shang)海交通大學(xue)、中(zhong)國(guo)中(zhong)醫(yi)(yi)科(ke)(ke)學(xue)院(yuan)基(ji)礎理(li)論所、圣(sheng)和藥業、三(san)胞集(ji)團natali公司等合作(zuo),真正(zheng)實現(xian)多學(xue)科(ke)(ke)、多領域(yu)的協同創新。
醫(yi)(yi)(yi)院(yuan)近(jin)年(nian)來精神文(wen)明(ming)(ming)建設碩果累(lei)累(lei),先(xian)(xian)(xian)(xian)后(hou)涌現(xian)出全(quan)(quan)國(guo)三八紅旗集(ji)體、國(guo)家級和省(sheng)(sheng)(sheng)級青年(nian)文(wen)明(ming)(ming)號、省(sheng)(sheng)(sheng)市(shi)級巾幗示范(fan)崗、廳行風(feng)建設先(xian)(xian)(xian)(xian)進(jin)單(dan)位、全(quan)(quan)國(guo)五一勞動(dong)獎(jiang)章、全(quan)(quan)國(guo)巾幗崗位明(ming)(ming)星、省(sheng)(sheng)(sheng)勤廉標兵、省(sheng)(sheng)(sheng)十大醫(yi)(yi)(yi)德標兵、江(jiang)蘇(su)工匠(jiang)、省(sheng)(sheng)(sheng)十佳健(jian)康(kang)衛士等(deng)(deng)(deng)一批先(xian)(xian)(xian)(xian)進(jin)集(ji)體和模范(fan)人(ren)物。醫(yi)(yi)(yi)院(yuan)先(xian)(xian)(xian)(xian)后(hou)榮(rong)(rong)(rong)獲 “全(quan)(quan)國(guo)中(zhong)醫(yi)(yi)(yi)藥系統(tong)創先(xian)(xian)(xian)(xian)爭(zheng)優(you)(you)先(xian)(xian)(xian)(xian)進(jin)集(ji)體”、“全(quan)(quan)省(sheng)(sheng)(sheng)創先(xian)(xian)(xian)(xian)爭(zheng)優(you)(you)·爭(zheng)創群眾滿意窗(chuang)口(kou)服(fu)務(wu)單(dan)位”、“江(jiang)蘇(su)省(sheng)(sheng)(sheng)文(wen)明(ming)(ming)單(dan)位”等(deng)(deng)(deng)榮(rong)(rong)(rong)譽稱號。醫(yi)(yi)(yi)院(yuan)2020年(nian)抗擊新冠肺炎疫情期(qi)間,派出14名醫(yi)(yi)(yi)護人(ren)員馳援(yuan)湖北,榮(rong)(rong)(rong)獲省(sheng)(sheng)(sheng)最(zui)(zui)美(mei)醫(yi)(yi)(yi)務(wu)工作者、省(sheng)(sheng)(sheng)最(zui)(zui)美(mei)抗“疫”家庭(ting)等(deng)(deng)(deng)榮(rong)(rong)(rong)譽。
醫(yi)(yi)院(yuan)消化(hua)科(ke)(ke)(ke)(ke)(ke)(ke)為(wei)國(guo)(guo)家衛(wei)生部(bu)臨床重(zhong)點專科(ke)(ke)(ke)(ke)(ke)(ke)、國(guo)(guo)家中(zhong)醫(yi)(yi)藥管(guan)理局(ju)“十二(er)五”重(zhong)點專科(ke)(ke)(ke)(ke)(ke)(ke)建設項(xiang)目(mu);骨(gu)傷科(ke)(ke)(ke)(ke)(ke)(ke)、心血管(guan)科(ke)(ke)(ke)(ke)(ke)(ke)為(wei)國(guo)(guo)家中(zhong)醫(yi)(yi)藥管(guan)理局(ju)“十一五”重(zhong)點專科(ke)(ke)(ke)(ke)(ke)(ke);重(zhong)癥醫(yi)(yi)學科(ke)(ke)(ke)(ke)(ke)(ke)為(wei)國(guo)(guo)家中(zhong)醫(yi)(yi)藥管(guan)理局(ju)“十二(er)五”重(zhong)點專科(ke)(ke)(ke)(ke)(ke)(ke)培育(yu)項(xiang)目(mu);心內科(ke)(ke)(ke)(ke)(ke)(ke)、婦產科(ke)(ke)(ke)(ke)(ke)(ke)、呼(hu)吸科(ke)(ke)(ke)(ke)(ke)(ke)、消化(hua)科(ke)(ke)(ke)(ke)(ke)(ke)、骨(gu)傷科(ke)(ke)(ke)(ke)(ke)(ke)、腫瘤科(ke)(ke)(ke)(ke)(ke)(ke)、內分泌科(ke)(ke)(ke)(ke)(ke)(ke)、普外科(ke)(ke)(ke)(ke)(ke)(ke)、兒科(ke)(ke)(ke)(ke)(ke)(ke)、腎(shen)科(ke)(ke)(ke)(ke)(ke)(ke)、老(lao)年科(ke)(ke)(ke)(ke)(ke)(ke)、神經內科(ke)(ke)(ke)(ke)(ke)(ke)為(wei)江蘇省(sheng)中(zhong)醫(yi)(yi)重(zhong)點專科(ke)(ke)(ke)(ke)(ke)(ke)。醫(yi)(yi)院(yuan)同時擁有國(guo)(guo)家藥物臨床試驗(yan)機構(gou)15個專業及I期臨床試驗(yan)研究(jiu)室。
醫(yi)院目(mu)前員工1400多人(ren),其中(zhong)(zhong)(zhong)正副(fu)教授、主(zhu)任(ren)(ren)醫(yi)師、研究(jiu)員300余名(ming)(ming);擁(yong)有(you)省(sheng)國(guo)(guo)醫(yi)名(ming)(ming)師、全國(guo)(guo)名(ming)(ming)老中(zhong)(zhong)(zhong)醫(yi)師帶徒導(dao)師、省(sheng)名(ming)(ming)中(zhong)(zhong)(zhong)醫(yi)、省(sheng)名(ming)(ming)中(zhong)(zhong)(zhong)西醫(yi)結合(he)(he)專家(jia)34名(ming)(ming);博士、碩士導(dao)師71名(ming)(ming);11位專家(jia)享受政府(fu)特殊津(jin)貼;擁(yong)有(you)國(guo)(guo)家(jia)“優青”以(yi)及一批國(guo)(guo)家(jia)衛計委和(he)省(sheng)突出(chu)貢獻專家(jia)等重點(dian)人(ren)才項目(mu)328人(ren);國(guo)(guo)家(jia)中(zhong)(zhong)(zhong)醫(yi)藥管理局(ju)中(zhong)(zhong)(zhong)藥口(kou)服制劑釋藥系統重點(dian)研究(jiu)室獲(huo)批省(sheng)醫(yi)學(xue)創新(xin)團(tuan)隊(dui)(dui),2017年以(yi)院“名(ming)(ming)醫(yi)工程”為(wei)抓手,儲備(bei)和(he)搭(da)建“老、中(zhong)(zhong)(zhong)、青”相結合(he)(he)的中(zhong)(zhong)(zhong)西醫(yi)結合(he)(he)人(ren)才梯(ti)隊(dui)(dui)。醫(yi)院每年派出(chu)德(de)才兼(jian)備(bei)人(ren)才,完成援外援疆、對口(kou)支援等任(ren)(ren)務,為(wei)國(guo)(guo)爭(zheng)光(guang),為(wei)醫(yi)院添彩。
醫(yi)(yi)(yi)院(yuan)現有3.0T核磁共振(zhen)(MRI)、數(shu)字(zi)減影血(xue)管(guan)造(zao)影(DSA)、脊(ji)椎(zhui)微(wei)創(chuang)手術(shu)導航(hang)系統(tong)、復合(he)手術(shu)室(shi)等(deng)國(guo)際國(guo)內領先(xian)的(de)醫(yi)(yi)(yi)療(liao)(liao)(liao)(liao)設備。常規(gui)開展脊(ji)柱(zhu)微(wei)創(chuang)治(zhi)療(liao)(liao)(liao)(liao)(PELD)、心血(xue)管(guan)介(jie)(jie)入(PTCA)、冠脈搭(da)橋、心臟(zang)瓣膜置換(huan)、消化科(ke)介(jie)(jie)入(ERCP)等(deng)先(xian)進(jin)的(de)診(zhen)療(liao)(liao)(liao)(liao)技(ji)術(shu)。醫(yi)(yi)(yi)院(yuan)脊(ji)柱(zhu)微(wei)創(chuang)技(ji)術(shu)結合(he)傳統(tong)中(zhong)(zhong)醫(yi)(yi)(yi)藥治(zhi)療(liao)(liao)(liao)(liao)、甲狀腺疾病(bing)綜(zong)合(he)診(zhen)療(liao)(liao)(liao)(liao)、保膽取石(shi)、針刀技(ji)術(shu)、中(zhong)(zhong)西醫(yi)(yi)(yi)結合(he)溶石(shi)排(pai)石(shi)等(deng)為(wei)該院(yuan)特(te)(te)色技(ji)術(shu)。醫(yi)(yi)(yi)院(yuan)的(de)國(guo)家(jia)中(zhong)(zhong)醫(yi)(yi)(yi)藥管(guan)理局中(zhong)(zhong)西醫(yi)(yi)(yi)結合(he)糖尿病(bing)一體(ti)化診(zhen)療(liao)(liao)(liao)(liao)平臺(tai)建成,積極探索新的(de)診(zhen)療(liao)(liao)(liao)(liao)模式建設,優(you)化診(zhen)療(liao)(liao)(liao)(liao)流程。一批科(ke)室(shi)先(xian)后榮獲國(guo)家(jia)中(zhong)(zhong)醫(yi)(yi)(yi)藥管(guan)理局、省衛生(sheng)計(ji)生(sheng)委優(you)質(zhi)護(hu)理服務先(xian)進(jin)病(bing)房(fang)和全(quan)國(guo)中(zhong)(zhong)醫(yi)(yi)(yi)特(te)(te)色護(hu)理優(you)秀科(ke)室(shi)。醫(yi)(yi)(yi)院(yuan)檢驗科(ke)作為(wei)華(hua)東(dong)地區第二(er)家(jia)ISO15189認證單位,為(wei)臨床和科(ke)研提供穩定可靠(kao)的(de)實驗數(shu)據。
以上信息源自官網,數據截止至2021年4月,請以官網為準。